Toremifene in Treating Patients With Ovarian Cancer

NCT00003865 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: toremifene

Sponsor

George Washington University